Track the companies that matter to you. It's FREE! Click one of these fan favorites to get started: Apple; Google; Ford.



Why This Biotech Crushed the Market

In the following video, health care editor/analyst David Williamson discusses the FDA advisory committee vote that sent shares of Arena Pharmaceuticals soaring over 70% in a single day. Obesity drug lorcaserin received an 18-4 recommendation supporting approval. What does this vote mean for Arena's competitors, and is the company poised for monster returns? For a closer look, watch the video and Fool On.

Arena is on the cutting edge for obesity treatment, yet it isn't one of the many dynamic recommendations made to Motley Fool Rule Breakers subscribers over the years. Now's a great time to discover the next rule-breaking multibagger that the newsletter has unearthed. It's a free report. Want it? Get it.

David Williamson holds no position in any company mentioned. Click here to see his holdings and a short bio. The Motley Fool has a disclosure policy. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.

Read/Post Comments (2) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On May 14, 2012, at 2:05 PM, YnotBeHappy wrote:

    ARNA is going to do very big things.

  • Report this Comment On May 14, 2012, at 2:18 PM, bmc007 wrote:

    What happened to all the bashing & trashing you guys did of ARNA before the AdCom meeting? Now everyone and the village cat is singing it's praises. MF was one of the most persistent naysayers but luckily enough I ignored you guys and bought anyway. I'm up over 300% as of this moment.

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1886734, ~/Articles/ArticleHandler.aspx, 10/24/2016 12:38:41 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,227.96 82.25 0.45%
S&P 500 2,148.85 7.69 0.36%
NASD 5,300.96 43.56 0.83%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

10/24/2016 12:23 PM
ARNA $1.59 Up +0.02 +1.27%
Arena Pharmaceutic… CAPS Rating: **
OREX $2.83 Up +0.01 +0.35%
Orexigen Therapeut… CAPS Rating: *
VVUS $1.11 Up +0.01 +0.91%
VIVUS CAPS Rating: **